SHOX2 DNA methylation is a tumour marker in pleural effusions

Cancer Genomics and Proteomics

Volumn 10, Issue 5, 2013, Pages 217-223

  Ilse, Peter ^a   Biesterfeld, Stefan ^a   Pomjanski, Natalia ^a   Fink, Christian ^a   Schramm, Martin ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Biomarker; Breast cancer; Cytology; DNA methylation; Lung cancer; Malignant tumour; Pleural effusion; Quantitative methylation specific PCR; SHOX2

Indexed keywords

DNA; HOMEODOMAIN PROTEIN; TRANSCRIPTION FACTOR; TUMOR MARKER;

ADULT; AGED; ARTICLE; ASSAY; BREAST CANCER; CANCER CYTODIAGNOSIS; COHORT ANALYSIS; CONTROLLED STUDY; CYTOLOGY; DIAGNOSTIC KIT; DIAGNOSTIC TEST ACCURACY STUDY; DIGESTIVE SYSTEM CANCER; DNA METHYLATION; FEMALE; HISTOLOGY; HOMEOBOX; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; LEUKEMIA; LUNG CANCER; LUNG LAVAGE; LUNG NON SMALL CELL CANCER; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MALIGNANT PLEURA EFFUSION; MESOTHELIOMA; PLEURA EFFUSION; PLEURA FLUID; PLEURODESIS; PREDICTIVE VALUE; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SHORT STATURE HOMEOBOX GENE 2;

BIOMARKER; BREAST CANCER; CYTOLOGY; DNA METHYLATION; LUNG CANCER; MALIGNANT TUMOUR; PLEURAL EFFUSION; QUANTITATIVE METHYLATION-SPECIFIC PCR; SHOX2;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DNA METHYLATION; DNA, NEOPLASM; FEMALE; HOMEODOMAIN PROTEINS; HUMANS; MALE; MIDDLE AGED; PLEURAL EFFUSION; REAL-TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84886737618     PISSN: 11096535     EISSN: 17906245     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. European Commission: European social statistics - edition 2013. Publications Office of the European Union, Luxembourg, 2013.
2. Marel M, Zrustova M, Stasny B and Light RW: The incidence of pleural effusion in a well-defined region. Epidemiologic study in central Bohemia. Chest 104: 1486-1489, 1993.
3. Light RW: Clinical practice. Pleural effusion. N Engl J Med 346: 1971-1977, 2002.
4. Bedrossian CWM: Malignant Effusions: A Multimodal Approach to Cytologic Diagnosis: Igaku-Shoin, New York, 1994.
5. Motherby H, Nadjari B, Friegel P, Kohaus J, Ramp U and Bocking A: Diagnostic accuracy of effusion cytology. Diagn Cytopathol 20: 350-357, 1999.
6. Rodriguez-Panadero F, Borderas Naranjo F and Lopez Mejias J: Pleural metastatic tumours and effusions. Frequency and pathogenic mechanisms in a post-mortem series. Eur Respir J 2: 366-369, 1989.
7. Antony VB, Loddenkemper R, Astoul P, Boutin C, Goldstraw P, Hott J, Rodriguez Panadero F and Sahn SA: Management of malignant pleural effusions. Eur Respir J 18: 402-419, 2001.
8. Bedrossian CW: Diagnostic problems in serous effusions. Diagn Cytopathol 19: 131-137, 1998.
9. Mohanty SK and Dey P: Serous effusions: diagnosis of malignancy beyond cytomorphology. An analytic review. Postgrad Med J 79: 569-574, 2003.
10. Sriram KB, Relan V, Clarke BE, Duhig EE, Yang IA, Bowman RV, Lee YC and Fong KM: Diagnostic molecular biomarkers for malignant pleural effusions. Future Oncol 7: 737-752, 2011.
11. Ting AH, McGarvey KM and Baylin SB: The cancer epigenome-components and functional correlates. Genes Dev 20: 3215-3231, 2006.
12. Esteller M: Cancer epigenomics: DNA methylomes and histone-modification maps. Nat Rev Genet 8: 286-298, 2007.
13. Laird PW: The power and the promise of DNA methylation markers. Nat Rev Cancer 3: 253-266, 2003.
14. Schmiemann V, Bocking A, Kazimirek M, Onofre AS, Gabbert HE, Kappes R, Gerharz CD and Grote HJ: Methylation assay for the diagnosis of lung cancer on bronchial aspirates: a cohort study. Clin Cancer Res 11: 7728-7734, 2005.
15. Belinsky SA, Liechty KC, Gentry FD, Wolf HJ, Rogers J, Vu K, Haney J, Kennedy TC, Hirsch FR, Miller Y, Franklin WA, Herman JG, Baylin SB, Bunn PA and Byers T: Promoter hypermethylation of multiple genes in sputum precedes lung cancer incidence in a high-risk cohort. Cancer Res 66: 3338-3344, 2006.
16. Palmisano WA, Divine KK, Saccomanno G, Gilliland FD, Baylin SB, Herman JG and Belinsky SA: Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res 60: 5954-5958, 2000.
17. Hsu HS, Chen TP, Hung CH, Wen CK, Lin RK, Lee HC and Wang YC: Characterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in plasma. Cancer 110: 2019-2026, 2007.
18. Benlloch S, Galbis-Caravajal JM, Martin C, Sanchez-Paya J, Rodriguez-Paniagua JM, Romero S, Mafe JJ and Massuti B: Potential diagnostic value of methylation profile in pleural fluid and serum from cancer patients with pleural effusion. Cancer 107: 1859-1865, 2006.
19. Schneider KU, Dietrich D, Fleischhacker M, Leschber G, Merk J, Schaper F, Stapert HR, Vossenaar ER, Weickmann S, Liebenberg V, Kneip C, Seegebarth A, Erdogan F, Rappold G and Schmidt B: Correlation of SHOX2 gene amplification and DNA methylation in lung cancer tumors. BMC Cancer 11: 102, 2011.
20. Dietrich D, Kneip C, Raji O, Liloglou T, Seegebarth A, Schlegel T, Flemming N, Rausch S, Distler J, Fleischhacker M, Schmidt B, Giles T, Walshaw M, Warburton C, Liebenberg V and Field JK: Performance evaluation of the DNA methylation biomarker SHOX2 for the aid in diagnosis of lung cancer based on the analysis of bronchial aspirates. Int J Oncol 40: 825-832, 2012.
21. Schmidt B, Liebenberg V, Dietrich D, Schlegel T, Kneip C, Seegebarth A, Flemming N, Seemann S, Distler J, Lewin J, Tetzner R, Weickmann S, Wille U, Liloglou T, Raji O, Walshaw M, Fleischhacker M, Witt C and Field JK: SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer based on bronchial aspirates. BMC Cancer 10: 600, 2010.
22. Blaschke RJ, Hahurij ND, Kuijper S, Just S, Wisse LJ, Deissler K, Maxelon T, Anastassiadis K, Spitzer J, Hardt SE, Scholer H, Feitsma H, Rottbauer W, Blum M, Meijlink F, Rappold G and Gittenberger-de Groot AC: Targeted mutation reveals essential functions of the homeodomain transcription factor Shox2 in sinoatrial and pacemaking development. Circulation 115: 1830-1838, 2007.
23. Blaschke RJ, Monaghan AP, Schiller S, Schechinger B, Rao E, Padilla-Nash H, Ried T and Rappold GA: SHOT, a SHOX-related homeobox gene, is implicated in craniofacial, brain, heart, and limb development. Proc Natl Acad Sci USA 95: 2406-2411, 1998.
24. Clement-Jones M, Schiller S, Rao E, Blaschke RJ, Zuniga A, Zeller R, Robson SC, Binder G, Glass I, Strachan T, Lindsay S and Rappold GA: The short stature homeobox gene SHOX is involved in skeletal abnormalities in Turner syndrome. Hum Mol Genet 9: 695-702, 2000.
25. Kneip C, Schmidt B, Seegebarth A, Weickmann S, Fleischhacker M, Liebenberg V, Field JK and Dietrich D: SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer in plasma. J Thorac Oncol 6: 1632-1638, 2011.
26. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408, 2001.
27. R Core Team. R: A language and environment for statistical computing. 2013 (cited Sep. 2013); Available from: http://www.R-project.org.
28. Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC and Muller M: pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics 12: 77, 2011.
29. Schaarschmidt F. bdpv: Inference and design for predictive values in binary diagnostic tests. 2012 (cited Sep. 2013); Available from: http://CRAN.R-project.org/package=bdpv.
30. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, Lijmer JG, Moher D, Rennie D and de Vet HC: Standards for Reporting of Diagnostic Accuracy. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. BMJ 326: 41-44, 2003.
31. Heller G, Babinsky VN, Ziegler B, Weinzierl M, Noll C, Altenberger C, Mullauer L, Dekan G, Grin Y, Lang G, End-Pfutzenreuter A, Steiner I, Zehetmayer S, Dome B, Arns BM, Fong KM, Wright CM, Yang IA, Klepetko W, Posch M, Zielinski CC and Zochbauer-Muller S: Genome-wide CpG island methylation analyses in non-small cell lung cancer patients. Carcinogenesis 34: 513-521, 2013.
32. Brock MV, Hooker CM, Yung R, Guo M, Han Y, Ames SE, Chang D, Yang SC, Mason D, Sussman M, Baylin SB and Herman JG: Can we improve the cytologic examination of malignant pleural effusions using molecular analysis? Ann Thorac Surg 80: 1241-1247, 2005.